What Did Stimulant-Involved Cardiovascular Death Certificates Measure?
Counting a stimulant on a death certificate is not the same task as counting deaths whose underlying cause was overdose. Harris and colleagues deliberately selected cardiovascular disease as the underlying cause and stimulant involvement as a contributing cause.
A defined death-certificate question
The supplied 2025 study used US National Vital Statistics System records for 2014–2022 and provisional 2023 data. Cardiovascular disease had to be the underlying cause, coded I00–I99. Cocaine or the stimulant category interpreted as methamphetamine had to appear as a contributing cause.
The methods list F15 and T43.6 for the latter classification. Those are administrative coding criteria, not reported compound-specific confirmatory concentrations. The article’s methamphetamine terminology should be read alongside the actual codes rather than treated as a laboratory identification for each death.
Rates and changes are different numbers
The authors reported an average annual percent change of 10.1% in age-adjusted stimulant-involved cardiovascular mortality, compared with 0.2% for overall cardiovascular mortality. The reported category-specific annual changes were 13.8% for methamphetamine involvement and 6.5% for cocaine involvement.
These describe trends in population mortality rates under the study definition. They are not the probability that an exposed person will die, the proportion of all overdoses involving a stimulant, or a change in the dose used by any individual. They also do not establish that every cardiovascular condition increased at the same rate.
What years of life lost can establish
The investigators estimated nearly one million years of life lost using ages at death and demographic-specific life expectancies. This is a modeled burden measure. The authors explicitly caution that comorbidities and other risk factors could shorten the decedents’ expected lives independently, making the estimate an upper-bound interpretation of stimulant-related burden.
It would therefore be unsupported to assign all of those modeled years exclusively to stimulant exposure or to say a particular decedent would otherwise have lived to the reference life expectancy.
Documentation remains part of the measurement
Death-certificate coding, incomplete histories and variation in investigation and toxicology can affect which deaths meet the definition. The study supplies evidence of a marked recorded population trend. It does not replace the case-specific work needed to identify the contribution of disease, substances and other circumstances in an individual death.
Source
Harris RA, Khatana SAM, Glei DA, Long JA. Stimulant-Involved Cardiovascular Disease Mortality and Life Years Lost, 2014 to 2023. Substance Use: Research and Treatment. 2025;19. DOI: 10.1177/29768357251342744. Based solely on the supplied paper.



